Here are Monday’s biggest calls on Wall Street: Goldman Sachs initiates Ferrari as buy Goldman said the luxury vehicle company is firing on all cylinders. “We initiate with a Buy rating on Ferrari as we see a large volume of higher-priced Special Series volumes driving ASP growth for the company …
Stocks bounced back Friday, but not enough to recover the week’s earlier losses. All three major averages posted gains — with the Dow Jones Industrial Average and the S & P 500 each adding about 1%, while the Nasdaq Composite advanced 0.9% — after New York Fed President John Williams …
It was a volatile week for the stock market, with the Dow Jones Industrial Average hitting an all-time high before pulling back. Wall Street pulled money away from Big Tech and into more defensive sectors, such as health care and financials. The end of the longest-ever U.S. government shutdown and …
“Let’s start with something simple. I cannot recall a time this year when it feels this good to be diversified among a whole host of terrific growth stocks, because growth of all kinds always works. Until now, it’s been terrific for all of 2025 to own nothing but data center, …
It was a terrible start to November on Wall Street. The tech-heavy Nasdaq sank just over 3% in its worst weekly performance since early April. The S & P 500 fell 1.6% for the week. Both stock measures broke three-week winning streaks.This week’s market decline, which followed a strong October, …
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in …
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of …
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied. From fresh competition to new uses, the market is quickly vaulting …
Third-quarter earnings reports, the Federal Reserve’s latest rate decision, and developments in the China-U.S. trade war led to some wild swings in the stock market. However, all three benchmark gauges — the S & P 500 , Nasdaq , and Dow — managed to finish in the green for the …
A strong start to the third-quarter earnings season has propelled the stock market back to record highs. Investors are hoping an even busier week of corporate reports — oh, and a Fed meeting — can keep the good times rolling. A wild card: President Donald Trump is in Asia for …
